Skip to main content
MyCapitol LogoMyCapitol

S 4338 · 117th Congress

Increasing Transparency in Generic Drug Applications Act

This bill requires the FDA to be more open about what happens when companies apply to sell generic versions of brand-name drugs. Right now, when a pharmaceutical company submits an application to make a generic drug, much of that information stays confidential. This bill would require the FDA to publicly disclose de…

Sponsor
Hassan, Margaret Wood (D-NH)
Introduced
2022-05-26
Policy area
Health
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Digging through Congress... 🔍